Project Details
Description
A randomized, placebo-controlled, double-blind, parallel-group, multi-center, exploratory dose-response study to assess the efficacy and safety of different oral doses of BAY 1128688 in women with symptomatic endometriosis over a 12-week treatment periode
| Status | Finished |
|---|---|
| Effective start/end date | 01/12/2017 → 04/01/2020 |